AMRX
Price
$7.75
Change
-$0.21 (-2.64%)
Updated
Jun 13 closing price
Capitalization
1.87B
53 days until earnings call
ANIP
Price
$62.56
Change
+$0.44 (+0.71%)
Updated
Jun 13 closing price
Capitalization
1.43B
52 days until earnings call
Interact to see
Advertisement

AMRX vs ANIP

Header iconAMRX vs ANIP Comparison
Open Charts AMRX vs ANIPBanner chart's image
Amneal Pharmaceuticals
Price$7.75
Change-$0.21 (-2.64%)
Volume$1.4M
Capitalization1.87B
ANI Pharmaceuticals
Price$62.56
Change+$0.44 (+0.71%)
Volume$150.69K
Capitalization1.43B
AMRX vs ANIP Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. ANIP commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and ANIP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (AMRX: $7.75 vs. ANIP: $62.56)
Brand notoriety: AMRX and ANIP are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 75% vs. ANIP: 39%
Market capitalization -- AMRX: $1.87B vs. ANIP: $1.43B
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. ANIP’s [@Pharmaceuticals: Other] market capitalization is $1.43B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileANIP’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • ANIP’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRX is a better buy in the long-term than ANIP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 5 TA indicator(s) are bullish while ANIP’s TA Score has 6 bullish TA indicator(s).

  • AMRX’s TA Score: 5 bullish, 4 bearish.
  • ANIP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, ANIP is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +1.71% price change this week, while ANIP (@Pharmaceuticals: Other) price change was +0.97% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.40%. For the same industry, the average monthly price growth was +14.50%, and the average quarterly price growth was +66.97%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

ANIP is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-0.40% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than ANIP($1.43B). AMRX has higher P/E ratio than ANIP: AMRX (90.00) vs ANIP (79.85). ANIP YTD gains are higher at: 13.169 vs. AMRX (-2.146). AMRX has higher annual earnings (EBITDA): 400M vs. ANIP (107M). ANIP has more cash in the bank: 221M vs. AMRX (91.5M). ANIP has less debt than AMRX: ANIP (286M) vs AMRX (2.75B). AMRX has higher revenues than ANIP: AMRX (2.39B) vs ANIP (487M).
AMRXANIPAMRX / ANIP
Capitalization1.87B1.43B131%
EBITDA400M107M374%
Gain YTD-2.14613.169-16%
P/E Ratio90.0079.85113%
Revenue2.39B487M492%
Total Cash91.5M221M41%
Total Debt2.75B286M962%
FUNDAMENTALS RATINGS
AMRX vs ANIP: Fundamental Ratings
AMRX
ANIP
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
92
Overvalued
PROFIT vs RISK RATING
1..100
5945
SMR RATING
1..100
9991
PRICE GROWTH RATING
1..100
5551
P/E GROWTH RATING
1..100
2495
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMRX's Valuation (92) in the Pharmaceuticals Major industry is in the same range as ANIP (92) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's Profit vs Risk Rating (45) in the Pharmaceuticals Other industry is in the same range as AMRX (59) in the Pharmaceuticals Major industry. This means that ANIP’s stock grew similarly to AMRX’s over the last 12 months.

ANIP's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as AMRX (99) in the Pharmaceuticals Major industry. This means that ANIP’s stock grew similarly to AMRX’s over the last 12 months.

ANIP's Price Growth Rating (51) in the Pharmaceuticals Other industry is in the same range as AMRX (55) in the Pharmaceuticals Major industry. This means that ANIP’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's P/E Growth Rating (24) in the Pharmaceuticals Major industry is significantly better than the same rating for ANIP (95) in the Pharmaceuticals Other industry. This means that AMRX’s stock grew significantly faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXANIP
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
73%
Advances
ODDS (%)
Bullish Trend about 1 month ago
80%
Bullish Trend 26 days ago
74%
Declines
ODDS (%)
Bearish Trend 24 days ago
78%
Bearish Trend 3 days ago
70%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 4 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
71%
Bullish Trend 3 days ago
68%
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ARTMX34.55-0.37
-1.06%
Artisan Mid Cap Investor
GSESX61.68-0.81
-1.30%
Goldman Sachs US Equity Insights Svc
RAFGX43.39-0.60
-1.36%
American Funds AMCAP R6
VYRBX25.33-0.38
-1.48%
VY® Baron Growth R6
NWHHX14.49-0.27
-1.83%
Nationwide Bailard Cogntv Val Instl Svc

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
-2.64%
PAHC - AMRX
46%
Loosely correlated
-2.37%
EBS - AMRX
40%
Loosely correlated
-5.30%
AMPH - AMRX
39%
Loosely correlated
-2.34%
ZTS - AMRX
39%
Loosely correlated
-2.66%
VTRS - AMRX
38%
Loosely correlated
-1.87%
More

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with ORGO. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
+0.71%
ORGO - ANIP
48%
Loosely correlated
-3.15%
PRGO - ANIP
40%
Loosely correlated
-2.20%
DRRX - ANIP
38%
Loosely correlated
-3.91%
EBS - ANIP
31%
Poorly correlated
-5.30%
AMRX - ANIP
27%
Poorly correlated
-2.64%
More